Denagard 10

This page contains information on Denagard 10 for veterinary use.
The information provided typically includes the following:
  • Denagard 10 Indications
  • Warnings and cautions for Denagard 10
  • Direction and dosage information for Denagard 10

Denagard 10

This treatment applies to the following species:
Manufacturer: Novartis (Farm Animal)

(tiamulin hydrogen fumarate)

Type B Medicated Swine Feed

For manufacture of Type C medicated swine feed only

Active Ingredient

Tiamulin hydrogen fumarate: 10 g/lb

Ingredients: rice hulls, mineral oil, porcine gelatin

Do not feed undiluted.

Denagard 10 Indications

Amount of Type B Medicated Feed Per Ton of Feed

Tiamulin hydrogen fumarate in Complete Type C Medicated Feed Per Ton

Withdrawal Period
(days)

For treatment of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin

20 lb

200 g

7

For control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis

3.5 lb

35 g

2

For control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin

3.5 lb

35 g

2

Warnings

Observe withdrawal time shown in table above.

Keep out of reach of children. Avoid contact with skin. Direct contact with skin or mucous membranes may cause irritation.

Denagard 10 Caution

Do not feed undiluted. Do not use in feeds for animals other than swine. The effects of tiamulin on swine reproductive performance, pregnancy and lactation have not been determined. Swine being treated with Denagard (tiamulin) should not have access to feeds containing polyether ionophores (e.g., lasalocid, monensin, narasin, salinomycin and semduramicin) as adverse reactions may occur. If signs of toxicity occur, discontinue use.

Mixing Directions

Mix this medicated feed (Type B) with non-medicated feed ingredients to make a Type C medicated feed as follows:

Type C Medicated Feed Tiamulin grams/ton Feed

Pounds Medicated Feed (Type B)

Pounds Non-medicated Feed*

35

3.5

1996.5

200

20

1980

*When making an approved Type C medicated feed drug combination, the inclusion rate of this non-medicated feed should be adjusted for the amount of the other drug added to make such combination Type C medicated feed.

Storage

Store at or below 25°C (77°F). Temporary excursions to 40°C (104°F) permitted.

For more information or to report adverse effects, call Novartis Animal Health US, Inc. at 1-800-637-0281.

For a complete listing of adverse reactions for DENAGARD reported to CVM see:

http://www.fda.gov/AnimalVeterinary/SafetyHealth.

Denagard® is a registered trademark of Novartis AG.

Restricted Drug (California): Use only as directed.

NADA 139-472, Approved by FDA.

Marketed by: Novartis Animal Health US, Inc., Greensboro, NC 27408 U.S.A.

Net Weight:

Product #

 

35 lb (15.9 kg)

609425

NAH/DEN10-MF/TYPE B/BGL/8

02/13

NAC No.: 1114102.3

NOVARTIS ANIMAL HEALTH US, INC.
Farm Animal Business

1447 140TH ST., LARCHWOOD, IA, 51241
Order Desk:   800-843-3386
Technical Information:   800-843-3386
Fax:   336-387-1030
Website:   www.livestock.novartis.com
Email:   technical.services@novartis.com
Every effort has been made to ensure the accuracy of the Denagard 10 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web3)